928 related articles for article (PubMed ID: 18758412)
41. Serum prohepcidin level in myelodysplasia.
El Husseiny NM; Matter MM; Sabry RM; Amin IS
Scand J Clin Lab Invest; 2010 Sep; 70(5):343-6. PubMed ID: 20509758
[TBL] [Abstract][Full Text] [Related]
42. Ultrapure dialysate improves iron utilization and erythropoietin response in chronic hemodialysis patients - a prospective cross-over study.
Hsu PY; Lin CL; Yu CC; Chien CC; Hsiau TG; Sun TH; Huang LM; Yang CW
J Nephrol; 2004; 17(5):693-700. PubMed ID: 15593037
[TBL] [Abstract][Full Text] [Related]
43. Nutritional-inflammation status and resistance to erythropoietin therapy in haemodialysis patients.
Locatelli F; Andrulli S; Memoli B; Maffei C; Del Vecchio L; Aterini S; De Simone W; Mandalari A; Brunori G; Amato M; Cianciaruso B; Zoccali C
Nephrol Dial Transplant; 2006 Apr; 21(4):991-8. PubMed ID: 16384825
[TBL] [Abstract][Full Text] [Related]
44. Is hepcidin-25 a clinically relevant parameter for the iron status in hemodialysis patients?
Brătescu LO; Bârsan L; Munteanu D; Stancu S; Mircescu G
J Ren Nutr; 2010 Sep; 20(5 Suppl):S77-83. PubMed ID: 20797577
[TBL] [Abstract][Full Text] [Related]
45. Hepcidin expression and iron parameters change in Type 2 diabetic patients.
Jiang F; Sun ZZ; Tang YT; Xu C; Jiao XY
Diabetes Res Clin Pract; 2011 Jul; 93(1):43-8. PubMed ID: 21513996
[TBL] [Abstract][Full Text] [Related]
46. [Serum prohepcidin and other iron metabolism parameters in healthy adults].
Zekanowska E; Boinska J; Kwapisz J; Kedziora-Kornatowska K; Porzych K; Ratajczak M
Przegl Lek; 2011; 68(2):82-6. PubMed ID: 21751515
[TBL] [Abstract][Full Text] [Related]
47. The anemia of ageing is not associated with increased plasma hepcidin levels.
Lee P; Gelbart T; Waalen J; Beutler E
Blood Cells Mol Dis; 2008; 41(3):252-4. PubMed ID: 18676162
[TBL] [Abstract][Full Text] [Related]
48. Greater potency of darbepoetin-α than erythropoietin in suppression of serum hepcidin-25 and utilization of iron for erythropoiesis in hemodialysis patients.
Shoji S; Inaba M; Tomosugi N; Okuno S; Ichii M; Yamakawa T; Kurihara S
Eur J Haematol; 2013 Mar; 90(3):237-44. PubMed ID: 23281632
[TBL] [Abstract][Full Text] [Related]
49. Do serum hepcidin-25 levels correlate with oxidative stress in patients with chronic kidney disease not receiving dialysis?
Maruyama Y; Yokoyama K; Yamamoto H; Nakayama M; Hosoya T
Clin Nephrol; 2012 Oct; 78(4):281-6. PubMed ID: 22541685
[TBL] [Abstract][Full Text] [Related]
50. Credibility of the measurement of serum ferritin and transferrin receptor as indicators of iron deficiency anemia in hemodialysis patients.
Mahdavi MR; Makhlough A; Kosaryan M; Roshan P
Eur Rev Med Pharmacol Sci; 2011 Oct; 15(10):1158-62. PubMed ID: 22165676
[TBL] [Abstract][Full Text] [Related]
51. Hepcidin expression in patients with acute leukaemia.
Cheng PP; Sun ZZ; Jiang F; Tang YT; Jiao XY
Eur J Clin Invest; 2012 May; 42(5):517-25. PubMed ID: 22023453
[TBL] [Abstract][Full Text] [Related]
52. Involvement of hepcidin in the anemia of multiple myeloma.
Sharma S; Nemeth E; Chen YH; Goodnough J; Huston A; Roodman GD; Ganz T; Lichtenstein A
Clin Cancer Res; 2008 Jun; 14(11):3262-7. PubMed ID: 18519751
[TBL] [Abstract][Full Text] [Related]
53. Hepcidin, an acute-phase protein and a marker of inflammation in kidney transplant recipients with and without coronary artery disease.
Malyszko J; Malyszko JS; Pawlak K; Mysliwiec M
Transplant Proc; 2006 Nov; 38(9):2895-8. PubMed ID: 17112858
[TBL] [Abstract][Full Text] [Related]
54. [Influence of tumor necrosis factor-alpha and interferon-gamma on erythropoietin production and erythropoiesis in cancer patients with anemia].
Wang W; Zhang MH; Yu Y; Xu CG
Zhonghua Xue Ye Xue Za Zhi; 2007 Oct; 28(10):681-4. PubMed ID: 18399174
[TBL] [Abstract][Full Text] [Related]
55. Hepcidin, iron status, and renal function in chronic renal failure, kidney transplantation, and hemodialysis.
Malyszko J; Malyszko JS; Pawlak K; Mysliwiec M
Am J Hematol; 2006 Nov; 81(11):832-7. PubMed ID: 16929540
[TBL] [Abstract][Full Text] [Related]
56. Monitoring iron status in end-stage renal disease patients on hemodialysis.
Rafi A; Karkar A; Abdelrahman M
Saudi J Kidney Dis Transpl; 2007 Mar; 18(1):73-8. PubMed ID: 17237895
[TBL] [Abstract][Full Text] [Related]
57. Serum hepcidin-25 levels and anemia in non-dialysis chronic kidney disease patients: a cross-sectional study.
Uehata T; Tomosugi N; Shoji T; Sakaguchi Y; Suzuki A; Kaneko T; Okada N; Yamamoto R; Nagasawa Y; Kato K; Isaka Y; Rakugi H; Tsubakihara Y
Nephrol Dial Transplant; 2012 Mar; 27(3):1076-83. PubMed ID: 21799206
[TBL] [Abstract][Full Text] [Related]
58. Long-term erythropoietin therapy does not affect metalloproteinases and their inhibitor levels, oxidative stress and inflammation in hemodialyzed patients.
Pawlak K; Pawlak D; Mysliwiec M
Am J Nephrol; 2007; 27(3):221-5. PubMed ID: 17384500
[TBL] [Abstract][Full Text] [Related]
59. Serum prohepcidin levels correlate with hepatic iron stores in chronic hepatitis C patients.
Lin TJ; Liao LY; Chou JM; Liu SO; Wang CK
Hepatogastroenterology; 2009; 56(93):1146-51. PubMed ID: 19760959
[TBL] [Abstract][Full Text] [Related]
60. Effect of repeated intravenous iron administration in haemodialysis patients on serum 8-hydroxy-2'-deoxyguanosine levels.
Maruyama Y; Nakayama M; Yoshimura K; Nakano H; Yamamoto H; Yokoyama K; Lindholm B
Nephrol Dial Transplant; 2007 May; 22(5):1407-12. PubMed ID: 17264097
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
